this time featuring more clinical than preclinical research updates. That’s not to say there aren’t any intriguing preclinical stories; it’s just that many of them seem too early-stage right now. I try to offer a glimpse of the future but also stay mindful of which developments might realistically take shape in the "near" term.
As usual...check your spam folder in case you have not received it.
Cheers!
Max
thank you for what you do here!
Thanks Max i love the idea of tumor revision.
Eh, who doesn't? Once you got the technique you could basically reverse any condition that is related to genetic mutations 😃 and no side effects!
Like they mentioned in the article everyone is different and it would need to be precision medicine. How do you design a trial where every subject needs to be treated based on their specific tumor micro environment and genetic?
Im thinking this is where AI will need to be the tool used administer the trial.
Phase 1 recruiting: QXL138AM, for CD138 expressing tumors
The Science is Coming as Fish Says
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
Understanding the Threat of Micrometastases (also known as Minimal Residual Disease) in Prostate Cancer or Don't sweat the small stuff 
Is It Just me? Lu-177 seems not to be as affective as once touted, seems Hyper / Hypo progression occurs in guys with mutations?
